Your browser doesn't support javascript.
loading
Berberine Alleviates Ischemic Brain Injury by Enhancing Autophagic Flux via Facilitation of TFEB Nuclear Translocation.
Liu, Yi-Li; Guo, Tao; Zhang, Yong-Jie; Tang, Shun-Cong; Zhao, Xiao-Ming; He, Hong-Yun; Yu, Chun-Lei; Deng, Yi-Hao.
Afiliação
  • Liu YL; School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming 650500, P. R. China.
  • Guo T; School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming 650500, P. R. China.
  • Zhang YJ; School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming 650500, P. R. China.
  • Tang SC; Anning First People's Hospital Affiliated to Kunming, University of Science and Technology Kunming 650500, P. R. China.
  • Zhao XM; School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming 650500, P. R. China.
  • He HY; School of Basic Medical Sciences, Kunming University of Science and Technology, Kunming 650500, P. R. China.
  • Yu CL; Anning First People's Hospital Affiliated to Kunming, University of Science and Technology Kunming 650500, P. R. China.
  • Deng YH; Anning First People's Hospital Affiliated to Kunming, University of Science and Technology Kunming 650500, P. R. China.
Am J Chin Med ; 52(1): 231-252, 2024.
Article em En | MEDLINE | ID: mdl-38328828
ABSTRACT
Berberine has been demonstrated to alleviate cerebral ischemia/reperfusion injury, but its neuroprotective mechanism has yet to be understood. Studies have indicated that ischemic neuronal damage was frequently driven by autophagic/lysosomal dysfunction, which could be restored by boosting transcription factor EB (TFEB) nuclear translocation. Therefore, this study investigated the pharmacological effects of berberine on TFEB-regulated autophagic/lysosomal signaling in neurons after cerebral stroke. A rat model of ischemic stroke and a neuronal ischemia model in HT22 cells were prepared using middle cerebral artery occlusion (MCAO) and oxygen-glucose deprivation (OGD), respectively. Berberine was pre-administered at a dose of 100[Formula see text]mg/kg/d for three days in rats and 90[Formula see text][Formula see text]M in HT22 neurons for 12[Formula see text]h. 24[Formula see text]h after MCAO and 2[Formula see text]h after OGD, the penumbral tissues and OGD neurons were obtained to detect nuclear and cytoplasmic TFEB, and the key proteins in the autophagic/lysosomal pathway were examined using western blot and immunofluorescence, respectively. Meanwhile, neuron survival, infarct volume, and neurological deficits were assessed to evaluate the therapeutic efficacy. The results showed that berberine prominently facilitated TFEB nuclear translocation, as indicated by increased nuclear expression in penumbral neurons as well as in OGD HT22 cells. Consequently, both autophagic activity and lysosomal capacity were simultaneously augmented to alleviate the ischemic injury. However, berberine-conferred neuroprotection could be greatly counteracted by lysosomal inhibitor Bafilomycin A1 (Baf-A1). Meanwhile, autophagy inhibitor 3-Methyladenine (3-MA) also slightly neutralized the pharmacological effect of berberine on ameliorating autophagic/lysosomal dysfunction. Our study suggests that berberine-induced neuroprotection against ischemic stroke is elicited by enhancing autophagic flux via facilitation of TFEB nuclear translocation in neurons.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Berberina / Lesões Encefálicas / Traumatismo por Reperfusão / Isquemia Encefálica / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Am J Chin Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Berberina / Lesões Encefálicas / Traumatismo por Reperfusão / Isquemia Encefálica / Acidente Vascular Cerebral / AVC Isquêmico Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Am J Chin Med Ano de publicação: 2024 Tipo de documento: Article